Wolf Lisa G reported TIVC

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001683168-25-009306

Machine-readable

Structured copy

Timestamps

Event (reported)

Dec 18, 2025

Published

Dec 22, 2025

Ingested by INSIDER

Nov 5, 04:26 UTC

Last re-read

Nov 5, 04:26 UTC

Extracted facts

Filer

Wolf Lisa G

Role

Chief Financial Officer

Transaction

Option exerciseAs filed: “M”

Asset

Tivic Health Systems, Inc.

Ticker

TIVC

Shares

736

Execution date (reported)

Dec 18, 2025

Owned after transaction

736 shares

Days from execution to publication

4

What this establishes

Wolf Lisa G filed this Form 4 reporting a option exercise of TIVC on Dec 18, 2025. It became public on Dec 22, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Financial Officer

Wolf Lisa Gcik:0001861556

Issuer

Valion Bio, Inc.cik:0001787740

Revision history · 0

No field has changed since this record was first ingested.